Events & News

Latest News

Dear All,

we are pleased to inform you of our participation at MEDLAB.

4 - 7 FEBRUARY 2019 - Dubai World Trade Centre

Visit us at our stand 

Exhibition Timings:
4 Feb 2019: 09:30 - 18:00
5 Feb 2019: 09:30 - 18:00
6 Feb 2019: 09:30 - 18:00
7 Feb 2019: 09:30 - 17:00
 
Congress Timings:
4 Feb 2019: 08:00 - 18:00
5 Feb 2019: 08:00 - 18:00
6 Feb 2019: 08:00 - 18:00
7 Feb 2019: 08:00 - 17:00

 

This new test allows the identification of the principal variants of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene through the Fluorescent ARMS (Amplification Refractory Mutation Detection System) from DNA extracted from whole blood and blood spot and the subsequent fragment analysis with an automated genetic analyzer.

 

 

Nuclear Laser Medicine participated in EQAS 2016 (External Quality Assurance Services) organized by the German association INSTAND e V. (Düsseldorf) for the analysis of  Hepatitis C virus geno-/subtyping with the test NLM Gen-C 2.0 AC004/24.

Genetic polymorphisms associated to coronary artery disease

Genetic test for 13,18,21, X and Y chromosome aneuploidies

Dear Customers and Partners,

Nuclear Laser Medicine will stay closed from Monday 13th until Friday 17th August due to the Summer Holidays. The activities will restart regularly on Monday 20th

 August.

Relax and Happy Holiday

Molecular test for the quantification of Hepatitis B (HBV-DNA) and Hepatitits C (HCV-RNA) in human p...

 

Nuclear Laser Medicine srl
Viale delle Industrie, 3 - 20090
Settala (MI) - ITALIA
Tel: +39 02 952451 - Fax: +39 02 95245238/37

P.Iva/Cod.Fisc.: 08763060152 - Cap. Soc. € 110.000,00 i.v.

 

CERTIFIED QUALITY

Nuclear Laser Medicine srl is certified